About
Biomotum develops soft robotic wearable exoskeleton devices designed for clinical rehabilitation to improve walking function in individuals with neurologic impairments such as cerebral palsy and stroke. Their SPARK system is currently being piloted with clinics and planned for an international launch in 2026.
Explore Biomotum's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.